KLRS vs AMGN: Which Stock is Better?
Side-by-side comparison of Kalaris Therapeutics Inc and Amgen Inc in 2026
KLRS
Kalaris Therapeutics Inc
$5.87
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | KLRS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $144.68M | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze KLRS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KLRS or AMGN a better investment?
Comparing KLRS and AMGN: Kalaris Therapeutics Inc has a market cap of $144.68M while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KLRS and AMGN?
KLRS (Kalaris Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KLRS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KLRS or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for KLRS.
Which company is more profitable: KLRS or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for KLRS.
Which is the larger company: KLRS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $144.68M for KLRS.
Should I buy KLRS or AMGN in 2026?
Both KLRS and AMGN have investment merit. KLRS trades at $5.87 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KLRS and AMGN stock?
Key differences: Market Cap ($144.68M vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).